FR2327764A1 - NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION - Google Patents

NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION

Info

Publication number
FR2327764A1
FR2327764A1 FR7630866A FR7630866A FR2327764A1 FR 2327764 A1 FR2327764 A1 FR 2327764A1 FR 7630866 A FR7630866 A FR 7630866A FR 7630866 A FR7630866 A FR 7630866A FR 2327764 A1 FR2327764 A1 FR 2327764A1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
new pharmaceutical
new
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7630866A
Other languages
French (fr)
Other versions
FR2327764B1 (en
Inventor
Lothar Ehrhardt
Volker Hartmann
Ludwig Patt
Karl-Heinz Otto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2327764A1 publication Critical patent/FR2327764A1/en
Application granted granted Critical
Publication of FR2327764B1 publication Critical patent/FR2327764B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7630866A 1975-10-17 1976-10-14 NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION Granted FR2327764A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (en) 1975-10-17 1975-10-17 Solid substances made from polyvinylpyrrolidone and ergot alkaloids

Publications (2)

Publication Number Publication Date
FR2327764A1 true FR2327764A1 (en) 1977-05-13
FR2327764B1 FR2327764B1 (en) 1979-03-02

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7630866A Granted FR2327764A1 (en) 1975-10-17 1976-10-14 NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION

Country Status (28)

Country Link
JP (1) JPS5854122B2 (en)
AT (1) AT362510B (en)
AU (1) AU508628B2 (en)
BE (1) BE847368A (en)
CA (1) CA1079641A (en)
CH (1) CH643737A5 (en)
CS (1) CS199647B2 (en)
DE (1) DE2546577B2 (en)
DK (1) DK146194C (en)
ES (1) ES452420A1 (en)
FI (1) FI762875A (en)
FR (1) FR2327764A1 (en)
GB (1) GB1560406A (en)
GR (1) GR61268B (en)
HK (1) HK3183A (en)
HU (1) HU172533B (en)
IE (1) IE43778B1 (en)
IL (1) IL50686A (en)
MY (1) MY8400063A (en)
NL (1) NL184558C (en)
NO (1) NO144468C (en)
NZ (1) NZ182341A (en)
PH (1) PH14513A (en)
PT (1) PT65719B (en)
SE (1) SE430379B (en)
SG (1) SG63082G (en)
SU (1) SU1165223A3 (en)
ZA (1) ZA766166B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454804A1 (en) * 1979-04-26 1980-11-21 Sanofi Sa DIHYDROERGOTOXIN-BASED MEDICINAL PRODUCT AND PROCESS FOR PREPARING THE SAME
FR2508313A1 (en) * 1981-06-24 1982-12-31 Sandoz Sa NOVEL PHARMACEUTICAL FORMULATIONS BASED ON Rye ERGAL ALKALOIDS AND THEIR PREPARATION
EP0277092A1 (en) * 1987-01-14 1988-08-03 Ciba-Geigy Ag Therapeutic system for slightly soluble active ingredients
FR2610827A1 (en) * 1987-02-18 1988-08-19 Pf Medicament HYDROPHILIC MATRIX DIHYDROERGOTAMINE (D.H.E.) COMPRESSOR AND METHOD FOR MANUFACTURING SAME
EP0664131A1 (en) * 1994-01-21 1995-07-26 Krewel Meuselbach GmbH Kava extracts with optimal release
WO2001039742A2 (en) * 1999-12-03 2001-06-07 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
WO1980001242A1 (en) * 1978-12-21 1980-06-26 Sandoz Ag Galenical preparation
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
DK1039908T3 (en) * 1997-12-22 2004-05-03 Schering Corp Preparation containing a molecular dispersion with increased bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PT1638527E (en) * 2003-06-27 2007-02-28 Bioprogress Spa Composite product obtainable by cogrinding of an active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454804A1 (en) * 1979-04-26 1980-11-21 Sanofi Sa DIHYDROERGOTOXIN-BASED MEDICINAL PRODUCT AND PROCESS FOR PREPARING THE SAME
FR2508313A1 (en) * 1981-06-24 1982-12-31 Sandoz Sa NOVEL PHARMACEUTICAL FORMULATIONS BASED ON Rye ERGAL ALKALOIDS AND THEIR PREPARATION
EP0277092A1 (en) * 1987-01-14 1988-08-03 Ciba-Geigy Ag Therapeutic system for slightly soluble active ingredients
FR2610827A1 (en) * 1987-02-18 1988-08-19 Pf Medicament HYDROPHILIC MATRIX DIHYDROERGOTAMINE (D.H.E.) COMPRESSOR AND METHOD FOR MANUFACTURING SAME
EP0280613A1 (en) * 1987-02-18 1988-08-31 Pierre Fabre Medicament Dihydroergotamine (D.H.E.) tablet of the hydrophilic-matrix type, and process for its production
EP0664131A1 (en) * 1994-01-21 1995-07-26 Krewel Meuselbach GmbH Kava extracts with optimal release
WO2001039742A2 (en) * 1999-12-03 2001-06-07 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
WO2001039742A3 (en) * 1999-12-03 2001-12-13 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
EP1512403A1 (en) * 1999-12-03 2005-03-09 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof

Also Published As

Publication number Publication date
CA1079641A (en) 1980-06-17
DE2546577A1 (en) 1977-04-21
PH14513A (en) 1981-08-24
FI762875A (en) 1977-04-18
BE847368A (en) 1977-04-15
FR2327764B1 (en) 1979-03-02
NO763446L (en) 1977-04-19
NZ182341A (en) 1978-09-20
DK454176A (en) 1977-04-18
JPS5251014A (en) 1977-04-23
JPS5854122B2 (en) 1983-12-02
SU1165223A3 (en) 1985-06-30
SE430379B (en) 1983-11-14
NO144468B (en) 1981-06-01
NL7611295A (en) 1977-04-19
GR61268B (en) 1978-10-17
AT362510B (en) 1981-05-25
NL184558C (en) 1989-09-01
HK3183A (en) 1983-01-20
DK146194C (en) 1984-01-02
DK146194B (en) 1983-07-25
SG63082G (en) 1983-09-09
IL50686A (en) 1979-05-31
NO144468C (en) 1981-09-09
ATA767976A (en) 1980-10-15
NL184558B (en) 1989-04-03
HU172533B (en) 1978-09-28
PT65719A (en) 1976-11-01
IE43778B1 (en) 1981-05-20
DE2546577B2 (en) 1981-04-02
GB1560406A (en) 1980-02-06
CH643737A5 (en) 1984-06-29
ZA766166B (en) 1978-05-30
CS199647B2 (en) 1980-07-31
MY8400063A (en) 1984-12-31
AU1875476A (en) 1978-04-20
SE7611189L (en) 1977-04-18
PT65719B (en) 1978-06-12
ES452420A1 (en) 1978-04-16
IL50686A0 (en) 1976-12-31
IE43778L (en) 1977-04-17
AU508628B2 (en) 1980-03-27

Similar Documents

Publication Publication Date Title
FR2276832A1 (en) NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION
BE839615A (en) NEW AMIDINOURAES, THEIR PREPARATION AND THEIR USE
FR2327764A1 (en) NEW PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION
FR2347365A1 (en) TRANS-HEXAHYDRO-PYRIDO-INDOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE843152A (en) NEW CEPHALOSPORIMES, THEIR PREPARATION AND THEIR USE
BE832921A (en) NEW RIFAMYCINS AND THEIR PREPARATION
BE833369A (en) NEW BENZODIAZEPINES AND THEIR PREPARATION
BE841797A (en) PHOTOSENSITIVE COMPOSITIONS AND THEIR APPLICATION
FR2320745A1 (en) NEW ANTI-FLAMMATORY AGENTS IMIDAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
BE847165A (en) NEW DETERGENT COMPOSITIONS AND THEIR PREPARATION,
BE871857A (en) NEW DISUBSTITLED PIPERAZINES, THEIR METHODS OF PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE825982A (en) TRIAZOLOQUINAZOLINES AND THEIR PREPARATION
BE831041A (en) NEW GALENIC COMPOSITIONS AND THEIR PREPARATION
FR2318174A1 (en) DIEPOXY-ANDROSTANES AND THEIR PREPARATION
FR2310132A1 (en) 14B-HYDROXY-3-DESOXYCARDENOLIDES AND ANALOGUES THEREOF, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2313059A1 (en) NEW STABLE PHARMACEUTICAL SOLUTIONS AND THEIR PREPARATION
FR2340310A1 (en) SUBSTITUTED HYDRAZINOPHTALAZINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE869560R (en) NEW STABLE PHARMACEUTICAL SOLUTIONS AND THEIR PREPARATION
BE830442A (en) NEW BENZYLAMINES THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING
BE846502A (en) ANTIMICROBIAL AGENTS AND THEIR PREPARATION
BE826925A (en) NEW PYRROLODIAZEPINES AND THEIR PREPARATION
BE840608A (en) NEW PHARMACEUTICAL COMPOSITIONS
BE820256A (en) NEW PHENOXYALKYLAMINES AND THEIR PREPARATION
FR2287220A1 (en) NEW ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION PROCESS
FR2313358A1 (en) URETHANNE-POLYTHIOLS AND THEIR PREPARATION

Legal Events

Date Code Title Description
ST Notification of lapse